|
|
36 Winchester St
Lyttelton,
Christchurch
New Zealand
8082
Ph: +64 3 3288 688
Cell: 027 488 4375
Skype: murraylaugesen
laugesen@healthnz.co.nz
www.healthnz.co.nz
|
Health NEW ZEALAND
Ltd
Nicotine and tobacco researchers
Dr Murray Laugesen
QSO, MBChB, FAFPHM, FRCS, Dip Obst
Managing Director
|
April 2010.
Critique
of the WHO TobReg report on e-cigarettes
Murray
Laugesen
Report
on the scientific basis of tobacco regulation:
Third Report of a WHO Study Group
WHO
Study Group on Tobacco Product Regulation. © WHO
2009
http://whqlibdoc.who.int/publications/2009/9789241209557_eng.pdf
The
report on e-cigarettes or ENDS, Electronic
Nicotine Delivery Systems
– except that some do not contain any
nicotine. They are thus best defined as “devices
designed for the purpose of nicotine delivery to
the respiratory system in which tobacco is not
necessary for their operation.”
Abstract
of Critique: Swatting
insects instead of killing elephants.
If
tobacco smoking is the elephant in the room,
electronic cigarettes are like a buzzing insect.
The natural instinct is of course to kill the
buzzing insect first, just in case it might be
harmful. This hostile analogy however, ignores the
fact that smokers who like to smoke smoke either
tobacco or e-cigarettes, and a move to
e-cigarettes implies a move away from tobacco for
the smoker concerned. If the real aim is to end
cigarette smoking, banning e-cigarettes is not a
sensible first move and could be
counter-productive.
TobReg,
an advisory committee of the World Health
Organization, is in effect calling for a ban on
electronic cigarettes for the next 3 to 5 years
world-wide, until manufacturers apply and
regulators accept them as safe to medicinal
standards, this while TobReg permits the continued
sale of tobacco cigarettes.
As
of March 2010, e-cigarettes are not known to have
killed anyone anywhere, or caused any threat to
life, despite sales of 800,000 in the
USA
. The same cannot be said for smoking cessation
approved medicinals such as bupropion and
varenicline.
Tobacco
cigarettes are known to cause millions of deaths
world wide, and 140,000 per year in the
USA
.
TobReg
has previously made recommendations that WHO
should mandate some reduction in the emissions of
nine leading toxicants in tobacco smoke, good as
far as they went, but for the individual smoker,
those reductions are far exceeded by the lesser
emissions of e-cigarettes.[1]
TobReg
has almost nothing positive to say about
electronic cigarettes. This is surprising, and at
odds with what many smokers claim – that it
helps them stop smoking, or at least cut down. We
agree with TobReg that the evidence is lacking
whether e-cigarettes assist smokers to quit
smoking. Certainly, such claims would be
premature. Health New Zealand Ltd is involved in
various funding applications to repair this
deficit in scientific knowledge through randomized
controlled trials, but it will be 2013 or 2014
before results are available. Meantime, the
absence of proof is not proof that the devices are
ineffective, merely proof that research funds from
independent sources are scarce..
Claims
about safety. TobReg’s report “recommends
that claims that ENDS are safer than cigarettes,
or that they could be marketed as cigarette
substitutes, be prohibited until such claims are
substantiated by sufficient evidence to satisfy
their accuracy to independent scientific
organizations and regulatory authorities.”
This requires that in the case of the FDA,
manufacturers apply to conduct trials costing
millions of dollars and years of delay, which no
e-cigarette manufacturer to our knowledge has yet
embarked on.
In
view of the lack of notified side-effects from the
use of e-cigarettes, and the 50% risk of premature
death which smokers face if they continue to
smoke, Health New Zealand Ltd’s view is that
meantime distributors should be entitled to inform
smokers as the facts become available, and in lay
language. Health
New Zealand
research shows that e-cigarettes are safer (in
common parlance) than tobacco cigarettes:
1
Emissions from e-cigarettes are
less toxic and are less harmful to health;
Comparative emissions testing commissioned by
Health New Zealand Ltd that harmful cigarette
smoke emissions are almost entirely absent from
e-cigarette mist,[2]
or present in quantities about 100 times less than
in the case of tobacco cigarettes.
2
E-cigarettes do not cause burns
or fires. (There is no flame). Among over 1000
New Zealand
smokers, we found tobacco cigarettes had caused
burns in 60%, 5% requiring medical attention, and
fires in 7% in their lifetime.[3]
3
No evidence of harm in first day
users. In a cross-over study by the Clinical
Trials Research Unit, University of Auckland in
2008, questioning of 40 volunteers for adverse
effects after a day of use of the e-cigarette
(blinded for nicotine presence or absence), showed
no difference between either and nor when compared
with medicinal Nicorette inhaler.[4]
4
E-cigarettes did not grow
bacteria,1 whereas tobacco
cigarettes do, associated with inflammatory lung
disease.[5]
5
E-cigarettes do not produce
second-hand smoke. No sidestream smoke is
produced, nor any mainstream smoke; mist is
inhaled and some propylene glycol is exhaled.
Propylene glycol has been used in a children’s
hospital to reduce risk of influenza and colds.
6
E-cigarettes are as safe as
medicinal nicotine patches and gum with respect to
nitrosamine carcinogen content. (8ng /g)1
This is hundreds of times lower than the 2 ug/g
ceiling on nitrosamines recommended by this same
TobReg report. for smokeless tobacco.
7
E-cigarettes do not contain
tobacco and work by vaporization. Cigarettes
burn tobacco at much higher temperatures, which
break up the plant material to form small toxic
molecules.
Claims
that e-cigarettes are cigarette substitutes.
TobReg’s report recommends a prohibition on
claims that e-cigarettes are cigarette
substitutes. As TobReg fails to state whether in
their opinion, e-cigarettes are less harmful than
cigarettes, and fail to say whether they are more
harmful, TobReg is unable to say much.
Nevertheless, TobReg goes further and recommends
(governments) prohibit claims that e-cigarettes
are cigarette substitutes – presumably because
it implies they are being touted as safer than
cigarettes, and TobReg is not happy about
marketers making such claims until regulators
confirm this is true. This seems a constriction on
commercial speech.
Denial
of the harm reduction principle. This report
is a denial of the harm reduction principle, that
smokers unwilling to quit should be allowed to
maintain their previous behaviour if they must,
but be encouraged to do so in a safer way.
Reduction of relative harm is seen as not
permissible, unless near absolute reduction of
risk is proven. For example, condoms for safer
sex, seatbelts for safer driving, are accepted by
society, but electronic cigarettes for safer
inhalation of nicotine are not yet accepted by
TobReg.
Regulation
as medicines or as tobacco products? TobReg
recommends regulation of e-cigarettes as
medicines, and approval is acknowledged as
theoretically possible in the future. TobReg
opposes regulation of e-cigarettes as tobacco
products, but if regulated as tobacco products
wants them regulated as required under the
Framework Convention on Tobacco Control. However
e-cigarettes do not contain tobacco, and FCTC only
applies to products which do.
Regulation
as medicine and as recreational product is seen in
either/or terms, not both/and. TobReg proposes no
middle way to regulate e-cigarettes, as has been
suggested by the Royal College of Physicians
London tobacco working group,.[6]
which proposes lighter regulation to permit the
sale of non-medicinal cigarette substitutes.
Conclusion
The
report says nothing against continued sales of
recreational tobacco, and in effect, wants to put
e-cigarettes out of reach, regulated as medicines
- equivalent to a world wide ban on their sale if
governments adopted the recommendation, as none
have been approved as medicines and few if any are
likely to be approved in the next five years.
TobReg recommends virtually no claims should be
made of any kind in the meantime.
TobReg
assumes that e-cigarettes are a public health
threat. Certainly the global distribution of low
cost e-cigarettes not manufactured under any
recognized international controls, are a threat to
the high standards and huge investments required
to bring a medicine to market, which have created
a oligopolic market for major pharmaceutical
manufacturers of medicinal nicotine. But that is
not to say that e-cigarettes are a public health
threat in the same league as tobacco cigarettes,
which is the alternative.
TobReg goes after e-cigarettes with a
determination more logically directed at tobacco
cigarettes.
TobReg’s
report has little to say about patents in the
e-cigarette industry which are narrowly held and
not widely enforced. Fear of enforcement combined
with lack of enforcement promotes cheap products
and inhibits further investment in the industry.
This
TobReg report is written for governments and
regulators, but it is out of tune with many
smokers who, unasked, have told this author and
many others across the world, (www.vapersclub.com
) that these devices have helped them quit
smoking, cut down or “smoke” with reduced
risk.
TobReg
has failed to appreciate the potential of
e-cigarettes, preferring to focus on their current
imperfections. Yet e-cigarettes could be the next
best step, both for governments, as in
New Zealand
, obtaining only slow reduction in smoking despite
wide and subsidized use of NRT; and for those
continuing smokers, who have already tried and
failed to quit using NRT, facing a one in two risk
of dying early.
One
regulation size does not fit all and the TobReg
take on e-cigarettes does not assist recent moves
in
New Zealand
aiming to end tobacco cigarette sales by 2020.
E--cigarettes could be the catalyst society and
smokers need, for sweetening the implementation of
a national cigarette and tobacco sales ban, as
proposed this year by voluntary agencies. As
e-cigarettes are classifiable as tobacco products
under NZ law, regulation should be achievable to a
reasonable non-medicinal standard.
Competing
interests: In 2008, Health New Zealand
Ltd was commissioned by Ruyan to research the
Ruyan e-cigarette in 2008, but has no financial
interest in e-cigarettes or any e-cigarette
company. In 2009, Dr Laugesen was commissioned by
WHO along with Dr Richard O’Connor (
Roswell Park
USA
) to wrute a background paper for TobReg on
Electronic Cigarettes.
[3]
Smith J, Bullen C, Laugesen M, Glover M.
Cigarette fires and burns in a population of
New Zealand smokers. Tob Control 2009; 18:
29-33.
[4]
Bullen C, Glover M, Laugesen M, et al. Effect
of an e-cigarette on cravings and withdrawal,
acceptability and nicotine delivery:
Randomised cross-over trial. Tobacco Control,
in press, 2010. http://www.healthnz.co.nz/ecig_effect-2.pdf
[5]
Pauly JL, Smith LA, Rickert MH, et al. Review:
Is lung inflammation associated with microbes
and microbial toxins in cigarette tobacco
smoke? Immunol Res
2010 March.
On line
11 Sept 2009
. DOI 10.1007/s12026-009-8117-6.
[6]
Royal
College
of Physicians.
Ending tobacco smoking in
Britain
: radical strategies for prevention and harm
reduction in nicotine addiction. A report by
the Tobacco Advisory Group of the Royal
College of Physicians.
London
: RCP, Sept. 2008.
|